Clinically 0 10 0 10 O
node 11 15 11 15 O
negative 16 24 16 24 O
, 24 25 24 25 O
no 26 28 26 28 O
evidence 29 37 29 37 O
of 38 40 38 40 O
metastatic 41 51 41 51 B-cancer
disease 52 59 52 59 I-cancer

Clinically 0 10 60 70 O
â‰¤ 11 12 71 72 O
3 13 14 73 74 B-upper_bound
cm 15 17 75 77 I-upper_bound
unifocal 18 26 78 86 O
lesion 27 33 87 93 O
by 34 36 94 96 O
imaging 37 44 97 104 O
or 45 47 105 107 O
physical 48 56 108 116 O
examination 57 68 117 128 O

Female 0 6 129 135 B-gender
subjects 7 15 136 144 I-gender
of 16 18 145 147 O
childbearing 19 31 148 160 O
potential 32 41 161 170 O
must 42 46 171 175 O
be 47 49 176 178 O
willing 50 57 179 186 B-contraception_consent
to 58 60 187 189 I-contraception_consent
use 61 64 190 193 I-contraception_consent
an 65 67 194 196 I-contraception_consent
adequate 68 76 197 205 I-contraception_consent
method 77 83 206 212 I-contraception_consent
of 84 86 213 215 I-contraception_consent
contraception 87 100 216 229 I-contraception_consent
for 101 104 230 233 O
the 105 108 234 237 O
course 109 115 238 244 O
of 116 118 245 247 O
the 119 122 248 251 O
study 123 128 252 257 O
through 129 136 258 265 O
120 137 140 266 269 B-upper_bound
days 141 145 270 274 I-upper_bound
after 146 151 275 280 O
the 152 155 281 284 O
last 156 160 285 289 O
dose 161 165 290 294 O
of 166 168 295 297 O
study 169 174 298 303 O
medication 175 185 304 314 B-treatment

Has 0 3 315 318 O
a 4 5 319 320 O
diagnosis 6 15 321 330 O
of 16 18 331 333 O
immunodeficiency 19 35 334 350 B-chronic_disease
or 36 38 351 353 O
is 39 41 354 356 O
receiving 42 51 357 366 O
systemic 52 60 367 375 B-treatment
steroid 61 68 376 383 I-treatment
therapy 69 76 384 391 I-treatment
or 77 79 392 394 O
any 80 83 395 398 O
other 84 89 399 404 O
form 90 94 405 409 O
of 95 97 410 412 O
immunosuppressive 98 115 413 430 B-treatment
therapy 116 123 431 438 I-treatment
within 124 130 439 445 O
7 131 132 446 447 B-upper_bound
days 133 137 448 452 I-upper_bound
prior 138 143 453 458 I-upper_bound
to 144 146 459 461 O
the 147 150 462 465 O
first 151 156 466 471 O
dose 157 161 472 476 O
of 162 164 477 479 O
trial 165 170 480 485 O
treatment 171 180 486 495 O

Has 0 3 496 499 O
a 4 5 500 501 O
known 6 11 502 507 O
additional 12 22 508 518 O
malignancy 23 33 519 529 B-cancer
that 34 38 530 534 O
is 39 41 535 537 O
progressing 42 53 538 549 O
or 54 56 550 552 O
requires 57 65 553 561 O
active 66 72 562 568 O
treatment 73 82 569 578 B-treatment
in 83 85 579 581 O
the 86 89 582 585 O
last 90 94 586 590 B-upper_bound
5 95 96 591 592 I-upper_bound
years 97 102 593 598 I-upper_bound

Has 0 3 599 602 O
an 4 6 603 605 O
active 7 13 606 612 B-chronic_disease
infection 14 23 613 622 I-chronic_disease
requiring 24 33 623 632 O
systemic 34 42 633 641 B-treatment
therapy 43 50 642 649 I-treatment

Has 0 3 650 653 O
known 4 9 654 659 O
active 10 16 660 666 O
Hepatitis 17 26 667 676 B-chronic_disease
B 27 28 677 678 I-chronic_disease
( 29 30 679 680 O
e.g. 30 34 680 684 O
, 34 35 684 685 O
HBsAg 36 41 686 691 B-chronic_disease
reactive 42 50 692 700 I-chronic_disease
) 50 51 700 701 O
or 52 54 702 704 O
Hepatitis 55 64 705 714 B-chronic_disease
C 65 66 715 716 I-chronic_disease
( 67 68 717 718 O
e.g. 68 72 718 722 O
, 72 73 722 723 O
HCV 74 77 724 727 B-clinical_variable
RNA 78 81 728 731 I-clinical_variable
[ 82 83 732 733 O
qualitative 83 94 733 744 O
] 94 95 744 745 O
is 96 98 746 748 O
detected 99 107 749 757 O
) 107 108 757 758 O

Has 0 3 759 762 O
known 4 9 763 768 O
psychiatric 10 21 769 780 B-chronic_disease
or 22 24 781 783 I-chronic_disease
substance 25 34 784 793 I-chronic_disease
abuse 35 40 794 799 I-chronic_disease
disorders 41 50 800 809 I-chronic_disease
that 51 55 810 814 O
would 56 61 815 820 O
interfere 62 71 821 830 O
with 72 76 831 835 O
cooperation 77 88 836 847 O
with 89 93 848 852 O
the 94 97 853 856 O
requirements 98 110 857 869 O
of 111 113 870 872 O
the 114 117 873 876 O
trial 118 123 877 882 O

Has 0 3 883 886 O
primary 4 11 887 894 B-clinical_variable
lesion 12 18 895 901 I-clinical_variable
> 19 20 902 903 O
3 21 22 904 905 B-lower_bound
cm 23 25 906 908 I-lower_bound
in 26 28 909 911 O
size 29 33 912 916 O
radiographically 34 50 917 933 O
or 51 53 934 936 O
by 54 56 937 939 O
physical 57 65 940 948 O
examination 66 77 949 960 O

Has 0 3 961 964 O
received 4 12 965 973 O
a 13 14 974 975 O
live 15 19 976 980 B-treatment
vaccine 20 27 981 988 I-treatment
within 28 34 989 995 O
30 35 37 996 998 B-upper_bound
days 38 42 999 1003 I-upper_bound
of 43 45 1004 1006 O
planned 46 53 1007 1014 O
start 54 59 1015 1020 O
of 60 62 1021 1023 O
study 63 68 1024 1029 O
therapy 69 76 1030 1037 O

Histologically 0 14 1038 1052 O
proven 15 21 1053 1059 O
invasive 22 30 1060 1068 B-cancer
breast 31 37 1069 1075 I-cancer
carcinoma 38 47 1076 1085 I-cancer
with 48 52 1086 1090 O
triple 53 59 1091 1097 O
negative 60 68 1098 1106 O
receptor 69 77 1107 1115 O
status 78 84 1116 1122 O
( 85 86 1123 1124 O
Estrogen 86 94 1124 1132 B-treatment
receptor 95 103 1133 1141 I-treatment
, 103 104 1141 1142 O
Progesterone 105 117 1143 1155 B-treatment
receptor 118 126 1156 1164 I-treatment
and 127 130 1165 1168 O
HER2 131 135 1169 1173 B-treatment
negative 136 144 1174 1182 I-treatment
by 145 147 1183 1185 O
IHC 148 151 1186 1189 B-treatment
and 152 155 1190 1193 O
FISH 156 160 1194 1198 B-treatment
) 160 161 1198 1199 O

Hypersensitivity 0 16 1200 1216 O
to 17 19 1217 1219 O
pembrolizumab 20 33 1220 1233 B-allergy_name
or 34 36 1234 1236 O
any 37 40 1237 1240 O
of 41 43 1241 1243 O
its 44 47 1244 1247 O
excipients 48 58 1248 1258 O

Pathologically 0 14 1259 1273 O
proven 15 21 1274 1280 O
nodal 22 27 1281 1286 B-chronic_disease
disease 28 35 1287 1294 I-chronic_disease
at 36 38 1295 1297 O
diagnosis 39 48 1298 1307 O
is 49 51 1308 1310 O
not 52 55 1311 1314 O
allowed 56 63 1315 1322 O

Patients 0 8 1323 1331 O
who 9 12 1332 1335 O
are 13 16 1336 1339 O
weekly 17 23 1340 1346 O
positive 24 32 1347 1355 O
for 33 36 1356 1359 O
the 37 40 1360 1363 O
estrogen 41 49 1364 1372 O
or 50 52 1373 1375 O
progesterone 53 65 1376 1388 O
receptor 66 74 1389 1397 O
( 75 76 1398 1399 O
i.e. 76 80 1399 1403 O
, 80 81 1403 1404 O
< 82 83 1405 1406 O
or 84 86 1407 1409 O
= 87 88 1410 1411 O
10 89 91 1412 1414 B-upper_bound
% 91 92 1414 1415 I-upper_bound
) 92 93 1415 1416 O
are 94 97 1417 1420 O
eligible 98 106 1421 1429 O

Replacement 0 11 1430 1441 B-treatment
therapy 12 19 1442 1449 I-treatment
( 20 21 1450 1451 O
e.g. 21 25 1451 1455 O
, 25 26 1455 1456 O
thyroxine 27 36 1457 1466 B-treatment
, 36 37 1466 1467 O
insulin 38 45 1468 1475 B-treatment
, 45 46 1475 1476 O
or 47 49 1477 1479 O
physiologic 50 61 1480 1491 B-treatment
corticosteroid 62 76 1492 1506 I-treatment
replacement 77 88 1507 1518 I-treatment
therapy 89 96 1519 1526 I-treatment
for 97 100 1527 1530 O
adrenal 101 108 1531 1538 B-chronic_disease
or 109 111 1539 1541 O
pituitary 112 121 1542 1551 B-chronic_disease
insufficiency 122 135 1552 1565 I-chronic_disease
, 135 136 1565 1566 O
etc 137 140 1567 1570 O
. 140 141 1570 1571 O
) 141 142 1571 1572 O
is 143 145 1573 1575 O
not 146 149 1576 1579 O
considered 150 160 1580 1590 O
a 161 162 1591 1592 O
form 163 167 1593 1597 O
of 168 170 1598 1600 O
systemic 171 179 1601 1609 B-treatment
treatment 180 189 1610 1619 I-treatment

include 0 7 1620 1627 O
basal 8 13 1628 1633 B-cancer
cell 14 18 1634 1638 I-cancer
carcinoma 19 28 1639 1648 I-cancer
of 29 31 1649 1651 I-cancer
the 32 35 1652 1655 I-cancer
skin 36 40 1656 1660 I-cancer
, 40 41 1660 1661 O
squamous 42 50 1662 1670 B-cancer
cell 51 55 1671 1675 I-cancer
carcinoma 56 65 1676 1685 I-cancer
of 66 68 1686 1688 I-cancer
the 69 72 1689 1692 I-cancer
skin 73 77 1693 1697 I-cancer
, 77 78 1697 1698 O
DCIS 79 83 1699 1703 B-cancer
of 84 86 1704 1706 I-cancer
the 87 90 1707 1710 I-cancer
breast 91 97 1711 1717 I-cancer
, 97 98 1717 1718 O
or 99 101 1719 1721 O
in 102 104 1722 1724 O
situ 105 109 1725 1729 B-cancer
cervical 110 118 1730 1738 I-cancer
cancer 119 125 1739 1745 I-cancer
that 126 130 1746 1750 O
has 131 134 1751 1754 O
undergone 135 144 1755 1764 O
potentially 145 156 1765 1776 O
curative 157 165 1777 1785 B-treatment
therapy 166 173 1786 1793 I-treatment

pregnant 0 8 1794 1802 B-pregnancy

